Intellectus Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Intellectus Partners's LMAT Position: Q2 2026 in Review
Intellectus Partners increased its LeMaitre Vascular (LMAT) stake by 10% in Q2 2026, buying an estimated $21.5K and bringing the position to 2,250 shares worth $216K. The position accounts for 0.04% of the portfolio, ranked #297.
Intellectus Partners first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $223K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Intellectus Partners held 2,250 shares of LeMaitre Vascular worth $216K as of Q2 2026.
- Intellectus Partners bought 210 LeMaitre Vascular shares in Q2 2026, an estimated $21.5K.
- LeMaitre Vascular made up 0.04% of Intellectus Partners's portfolio in Q2 2026, its #297 holding.
- Intellectus Partners first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
- Intellectus Partners's LeMaitre Vascular position peaked at $223K in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.